Cultural Modification of an Evidence Based Healthy Lifestyle Intervention for People Post Stroke Who Identify as Hispanic/Latino

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this trial is to examine weight loss for Hispanic/Latino people with stroke (CVA) who take part in a healthy lifestyle program that has been culturally modified for Hispanic/Latino people

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• BMI ≥25

• Identify as Hispanic or Latino

• 18-85 years of age

• All types of stroke

• Medically able to participate in a weight-loss program

• Physical Activity Readiness Questionnaire +

• ≥12 months post first stroke

Locations
United States
Texas
Baylor Institute for Rehabilitation
RECRUITING
Dallas
Contact Information
Primary
Alvaro Carrera
alvaro.carrera@bswhealth.org
469-831-5321
Time Frame
Start Date: 2025-05-19
Estimated Completion Date: 2026-10-31
Participants
Target number of participants: 24
Treatments
Experimental: GLB CVA Latino
The GLB program, adapted for Latino individuals with stroke, will be delivered to participants over a 12-month period, divided into 22 in-person or virtual, group sessions. The goal of the GLB program is to help the participant achieve and maintain a 5-7% weight-loss using a two-pronged approach:~1. Physical activity: This is based upon recommendations by the American Heart Association and the American College of Sports Medicine (ACSM) to achieve 150 minutes of moderate intensity activity each week. Walking is the primary activity recommended.~2. Healthy eating: Based on United States Department of Agriculture guidelines, the GLB emphasizes healthy eating patterns and tracking dietary intake. Key recommendations include individuals consuming (1) a variety of vegetables, (2) whole fruits, (3) whole grains, (4) fat-free or low-fat dairy, (5) a variety of lean proteins, and (6) oils at every meal
Related Therapeutic Areas
Sponsors
Leads: Baylor Research Institute

This content was sourced from clinicaltrials.gov